Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of dual-energy X-ray absorptiometry and magnetic resonance imaging-measured adipose tissue depots in HIV-infected and control subjects.
Scherzer R, Shen W, Bacchetti P, Kotler D, Lewis CE, Shlipak MG, Punyanitya M, Heymsfield SB, Grunfeld C; Study of Fat Redistribution Metabolic Change in HIV Infection. Scherzer R, et al. Am J Clin Nutr. 2008 Oct;88(4):1088-96. doi: 10.1093/ajcn/88.4.1088. Am J Clin Nutr. 2008. PMID: 18842798 Free PMC article.
Regional adipose tissue and elevations in serum aminotransferases in HIV-infected individuals.
Tien PC, Kotler DP, Overton ET, Lewis CE, Rimland D, Bacchetti P, Scherzer R, Gripshover B; Study of Fat Redistribution and Metabolic Change in HIV Infection Investigators. Tien PC, et al. J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):169-76. doi: 10.1097/QAI.0b013e3181685700. J Acquir Immune Defic Syndr. 2008. PMID: 18285711 Free PMC article.
Simple anthropometric measures correlate with metabolic risk indicators as strongly as magnetic resonance imaging-measured adipose tissue depots in both HIV-infected and control subjects.
Scherzer R, Shen W, Bacchetti P, Kotler D, Lewis CE, Shlipak MG, Heymsfield SB, Grunfeld C; Study of Fat Redistribution Metabolic Change in HIV Infection (FRAM). Scherzer R, et al. Am J Clin Nutr. 2008 Jun;87(6):1809-17. doi: 10.1093/ajcn/87.6.1809. Am J Clin Nutr. 2008. PMID: 18541572 Free PMC article.
Evaluation of the virological and metabolic effects of switching protease inhibitor combination antiretroviral therapy to nevirapine-based therapy for the treatment of HIV infection.
Tebas P, Yarasheski K, Henry K, Claxton S, Kane E, Bordenave B, Klebert M, Powderly WG. Tebas P, et al. Among authors: yarasheski k. AIDS Res Hum Retroviruses. 2004 Jun;20(6):589-94. doi: 10.1089/0889222041217374. AIDS Res Hum Retroviruses. 2004. PMID: 15242534 Clinical Trial.
Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s).
Tebas P, Zhang J, Yarasheski K, Evans S, Fischl MA, Shevitz A, Feinberg J, Collier AC, Shikuma C, Brizz B, Sattler F; AIDS Clinical Trials Group (ACTG). Tebas P, et al. Among authors: yarasheski k. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):193-200. doi: 10.1097/QAI.0b013e318042e204. J Acquir Immune Defic Syndr. 2007. PMID: 17527093 Free PMC article. Clinical Trial.
196 results